Inventor
MARK ROGGE
Inventor
US
Overview
Patents· 2 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
PatentTitleYear
12,594,269Method for enhancing the pharmacokinetics or increasing the plasma concentration of methyl 3-((methylsulfonyl)amino)-2-(((4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate or a salt thereof with an inhibitor of cytochrome P450202612,290,513Therapeutic methods and compositions for treating movement disorders2025Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2025Patents assigned to VIMA THERAPEUTICS INC (1)· patent assignee history
2025–2026Based in US· patent location history
2026Patents assigned to TAKEDA PHARMACEUTICAL COMPANY LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LTD | 1 | 2026 |
| VIMA THERAPEUTICS INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 2 | 2025–2026 |